tysabri

Medimmune Teams with NIH on Vaccines and Biogen’s TYSABRI(R) ...
Financial News USA (press release) - La Puente,CA,USA
... Idec (NASDAQ: BIIB) and Elan Corporation, plc recently announced that they received approval from the European Commission to market TYSABRI® (natalizumab) as ...

EU approves Biogen's Tysabri to be sold for severe MS cases
Boston Globe - United States
... and Elan Corp.'s recalled multiple sclerosis drug Tysabri won approval by European regulators for patients with the severest cases of the disease. ...
See all stories on this topic

Mortgage interest rates rise
San Diego Union Tribune - United States
... Biogen Idec and Elan Corp. received European Commission approval to market their multiple sclerosis treatment Tysabri throughout the 25-nation bloc. ...